SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-11835"
 

Search: onr:"swepub:oai:DiVA.org:uu-11835" > Pharmacodynamic asp...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Pharmacodynamic aspects of intraperitoneal cytotoxic therapy

Ceelen, Wim P. (author)
Påhlman, Lars (author)
Uppsala universitet,Kolorektalkirurgi
Mahteme, Haile (author)
Uppsala universitet,Kolorektalkirurgi
 (creator_code:org_t)
2007
2007
English.
In: Cancer treatment and research. - 0927-3042. ; 134, s. 195-214
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The rationale for ip administration as an adjunct to surgery is firmly based on theoretical and pharmacokinetic grounds. The superiority of combined ip and intravenous chemotherapy over intravenous chemotherapy alone has been established in randomized trials in stage IIIc ovarian cancer patients. Intraoperative ip cytotoxic therapy results in a definite pharmacological advantage, since high peritoneal concentrations are achieved with limited systemic absorption. At present, however, it is not clearly established to what extent this PK advantage will result in enhanced anticancer activity and, ultimately, in a survival benefit. Preclinical models show that direct penetration into tumour tissue is limited to a few millimeters. Furthermore, the limited exposure time of intraoperative chemoperfusion could limit cytotoxic activity despite high local concentrations. Among the cytotoxic agents currently used, the pharmacodynamic aspects of the platinum compounds are the best studied both with and without associated hyperthermia. Newer agents such as the taxanes and the camptothecins appear promising for ip chemoperfusion during or immediately after surgery. Pharmacodynamic aspects of HIPEC needing further preclinical study-including mathematical modeling - are the establishment of tumour tissue penetration of the newer agents and its relation to hyperthermia, the definition of the relative contribution of direct penetration versus vascular supply by absorbed drug, and the efficacy of combined ip and intravenous regimens. Ultimately, however, randomised trials of ip chemotherapy with surgery will have to provide the evidence base to further build upon.

Keyword

Animals
Antineoplastic Agents/administration & dosage/pharmacokinetics/*pharmacology
Chemotherapy; Cancer; Regional Perfusion/*methods
Humans
Hyperthermia; Induced
Infusions; Parenteral/*methods
Neoplasms/drug therapy/*metabolism
Peritoneum/*metabolism
Tissue Distribution
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Ceelen, Wim P.
Påhlman, Lars
Mahteme, Haile
Articles in the publication
Cancer treatment ...
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view